Lodo Therapeutics

Developer novel therapeutics to treat resistant infectious diseases and cancers using AI

placeNew York City, New York, United States calendar_todayFounded 2015 groups24 employees language lodotherapeutics.com

Registered entities

Investor mix

13 investors on record.

Investor typeCountShare
Venture capital431%
Angel & family office18%
Other / undisclosed862%
Coming soon